OliX PharmaceuticalsInc (226950) — Cash Flow Reinvestment Rate
Latest as of September 2025:
33.72x
OliX PharmaceuticalsInc (226950) has a Cash Flow Reinvestment Rate of 33.72x as of September 2025, reinvesting ₩108.78 Billion (capex ₩623.14 Million plus investments ₩-108.16 Billion) from operating cash flow of ₩3.23 Billion. See how much free cash does OliX PharmaceuticalsInc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
33.72x
(Capex + Investments) / Operating CF
Total Reinvested
₩108.78 Billion
Capex + Investments
Operating Cash Flow
₩3.23 Billion
KRW
Capital Expenditures
₩623.14 Million
KRW
Annual Cash Flow Reinvestment Rate for OliX PharmaceuticalsInc (None–None)
Year-by-year capital reinvestment analysis for OliX PharmaceuticalsInc. See OliX PharmaceuticalsInc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow